secwatch.observer — SEC 8-K summary
======================================

Issuer:     VEEA INC. (VEEA)
CIK:        0001840317
Form:       8-K
Filed at:   2026-06-04T21:27:54+00:00
Accession:  0001213900-26-065392
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Veea loses board independence after director Douglas Maine death; Nasdaq grants cure period
--------------------------------------------------------------------------------

- Director Douglas Maine passed away June 1, 2026, reducing independent directors to 3 of 6.
- Veea is non-compliant with Nasdaq majority independent director rule (5605(b)(1)).
- Audit committee has only two independent directors; compensation committee has one independent director.
- Nasdaq cure period: until earlier of 2027 annual meeting or May 31, 2027 (or Nov 27, 2026 if annual meeting before then).
- VEEA and VEEAW continue trading on Nasdaq Capital Market; no immediate delisting effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840317/000121390026065392/0001213900-26-065392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840317/000121390026065392/ea0293670-8k_veea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-065392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer